Printer Friendly

RYAH Medtech partners with SOS Cannabis to provide free legal representation to Canadian patients seeking reimbursement of medical costs.

RYAH Medtech Inc is making it easier for Canadian patients to purchase its dose-measuring dry herb vaporizer by partnering up with SOS Cannabis.

The partnership will provide patients with the opportunity for free legal representation from the team at SOS when seeking reimbursement from government agencies for the costs of purchasing the RYAH vaporizer.

The vaporizer lets patients precisely measure the dose and temperature of their vaporizing sessions and uses HIPAA-compliant medical data to analyze what works for them. RYAH Medtech is a privately-held company based in New York.

WATCH: RYAH Medtech stocks the shelves with its cannabis vaporizer at Maryland dispensary

"As we enter the plant-based medicinal market in Canada with our Health Canada Class I licensed dry-herb cartridges and our dry-herb vaporizer, we will be providing consumers with a complete solution for dose-control, heating, consumption and feedback," RYAH CEO Greg Wagner said.

"The SOS Cannabis partnership takes our solution further by providing patients with the ability to seek reimbursement on RYAH products from governmental agencies, at no additional costs."

SOS Cannabis is a law firm based in Quebec that helps clients seek proactive and retroactive reimbursement for claims made to governmental organizations.

Contact Andrew Kessel at

Follow him on Twitter @andrew_kessel

To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link:

COPYRIGHT 2019 NLA Access Media Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Proactive Investors United States
Date:Jul 29, 2019
Previous Article:American Rebel Holdings begins shipping its full-size safes, expands into cannabis safes.
Next Article:Buds & Duds: Cannabis stocks have mixed start to week but Nextleaf shines on addition to OTC markets.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters